AU Research Fund (AURF Sample Clauses

AU Research Fund (AURF. (a) The University will continue to support the Algoma University Research Fund (AURF) from University-related research funds. Monies from AURF shall be allocated on an annual basis after an open competition, to the maximum available, for the purpose of encouraging and assisting research activity by faculty. All full-time faculty shall be eligible to apply. Grants to individual faculty members will not exceed $5,000. Funds are expected to cover the direct costs of research and use of funds is expected to result in successful application for external research funding or in peer-reviewed publications. (b) The Research Advisory Committee, chaired by the Vice President Academic and Research (VPAR), will determine the award criteria and will select the AURF recipients. The Research Advisory Committee will be composed of a Representative, with current research experience, from each Division elected annually. Decisions of the Research Advisory Committee will be binding. An application form and decision criteria are maintained by the Research Advisory Committee.
Sample 1Sample 2
AutoNDA by SimpleDocs
AU Research Fund (AURF a) The University will continue to support the Algoma University Research Fund (AURF) from University-related research funds. Monies from AURF shall be allocated on an annual basis after an open competition, to the maximum available, for the purpose of encouraging and assisting research activity by faculty. All full-time faculty shall be eligible to apply. Grants to individual faculty members will not exceed $5,000. Funds are expected to cover the direct costs of research and use of funds is expected to result in successful application for external research funding or in peer- reviewed publications. The Peer Review Committee will determine the award criteria and will select the AURF recipients. Decisions of the Peer Review Committee will be binding. An application form and decision criteria are maintained by the Peer Review Committee.
Sample 1

Related to AU Research Fund (AURF

  • Research Funding (a) During each Collaboration Term and in connection with any wind-down activities contemplated by Section 13.4. Gilead shall reimburse Hookipa for all Out-of-Pocket Costs actually incurred (with no markup) by Hookipa in connection with the applicable Program, to the extent specifically contemplated in the applicable Research Plan and in accordance with the applicable Research Budget. Gilead shall reimburse the undisputed amount of such Out-of-Pocket Costs incurred in a [***] within [***] days after receipt from Hookipa of an invoice therefor issued within [***] days after the end of such [***]. (b) During each Collaboration Term for a Program, Gilead shall reimburse Hookipa at the FTE Rate for the costs of any FTEs (not to exceed the number of FTEs specified in the applicable Research Plan for such Program for any period without first obtaining, in each case, Gilead’s prior written consent) actually performing activities allocated to Hookipa under such Research Plan. Hookipa shall provide to Gilead, within [***] days after the end of each [***] during each Collaboration Term, a report indicating the number of FTEs actually provided by Hookipa with respect to each Program during such [***], Hookipa shall use standard industry systems and processes to record the number of hours and FTEs actually applied to each Program, which systems and processes shall be consistently and equitably applied to all Hookipa research programs with Third Parties. Gilead shall reimburse Hookipa the undisputed amount for such FTE costs incurred in a [***] within [***] days after receipt from Hookipa of an invoice therefor issued within [***] days after the end of each [***]. (c) For clarity, Gilead shall not be obligated to reimburse Hookipa for any costs or expenses incurred by Hookipa in the course of its activities under the Programs, other than: (i) those costs and expenses expressly identified in this Section 9.6 or elsewhere in this Agreement; (ii) reimbursement for the supply of Licensed Products to Gilead in accordance with the terms of any supply agreement entered into by the Parties pursuant to Section 7.2; or (iii) any other costs and expenses approved by Gilead in writing in advance.

  • Technology Research Analyst Job# 1810 General Characteristics

  • Collaboration 31.1 If the Buyer has specified in the Order Form that it requires the Supplier to enter into a Collaboration Agreement, the Supplier must give the Buyer an executed Collaboration Agreement before the Start date. 31.2 In addition to any obligations under the Collaboration Agreement, the Supplier must: 31.2.1 work proactively and in good faith with each of the Buyer’s contractors 31.2.2 co-operate and share information with the Buyer’s contractors to enable the efficient operation of the Buyer’s ICT services and G-Cloud Services

  • Business Development Company Buyer is a business development company as defined in Section 202(a)(22) of the Investment Advisors Act of 1940.

  • Professional Development Fund Article 20

  • Multi-year Planning Targets Schedule A may reflect an allocation for the first Funding Year of this Agreement as well as planning targets for up to two additional years, consistent with the term of this Agreement. In such an event, the HSP acknowledges that if it is provided with planning targets, these targets: a. are targets only, b. are provided solely for the purposes of planning, c. are subject to confirmation, and d. may be changed at the discretion of the Funder in consultation with the HSP. The HSP will proactively manage the risks associated with multi-year planning and the potential changes to the planning targets; and the Funder agrees that it will communicate any changes to the planning targets as soon as reasonably possible.

  • Research Primary Investigator as part of a multi-site study (25 points) • Co-Investigator as part of a multi-site study (20 points) • Primary Investigator of a facility/unit based research study (15 points) • Co-Investigator of a facility/unit based research study (10 points) • Develops a unit specific research proposal (5 points) • Conducts a literature review as part of a research study (5 points)

  • Professional Development Funds 23.1.1 Two Professional Development Funds, a Professional Development Support Fund and an Education Leave Fund, shall be established to support professional development activities as defined in 23.2. On April 1st of each year, the College will allocate an amount equal to no less than 0.9% of total faculty salary (exclusive of severance payments) to the Professional Development Support Fund, and an amount equal to no less than 0.6% of total faculty salary to the Educational Leave Fund. Any unused balances in these funds shall carry over to the next budget year. 23.1.2 The College agrees to provide the Association with the authority to administer the program on behalf of the College for those activities approved by the College in accordance with 23.2, 23.4 and 23.5. 23.1.3 Nothing in this Agreement prevents the College from funding professional development activities in addition to those activities supported through the Professional Development Funds (23.1.1) in accordance with the procedures described in this Article.

  • Price Emerging Europe Fund  X Xxxx Price Emerging Markets Bond Fund X. Xxxx Price Emerging Markets Corporate Bond Fund X. Xxxx Price Emerging Markets Local Currency Bond Fund X. Xxxx Price Emerging Markets Stock Fund X. Xxxx Price Emerging Markets Value Stock Fund X. Xxxx Price European Stock Fund X. Xxxx Price Global Growth Stock Fund X. Xxxx Price Global High Income Bond Fund X. Xxxx Price Global Industrials Fund X. Xxxx Price Global Stock Fund X. Xxxx Price Global Unconstrained Bond Fund X. Xxxx Price International Bond Fund X. Xxxx Price International Concentrated Equity Fund X. Xxxx Price International Discovery Fund X. Xxxx Price International Growth & Income Fund X. Xxxx Price International Stock Fund X. Xxxx Price Japan Fund X. Xxxx Price Latin America Fund X. Xxxx Price New Asia Fund X. Xxxx Price Overseas Stock Fund X. XXXX PRICE INTERNATIONAL INDEX FUND, INC. X. Xxxx Price International Equity Index Fund X. XXXX PRICE INTERNATIONAL SERIES, INC. X. Xxxx Price International Stock Portfolio X. XXXX PRICE MEDIA & TELECOMMUNICATIONS FUND, INC. X. XXXX PRICE MID-CAP GROWTH FUND, INC. X. XXXX PRICE MID-CAP VALUE FUND, INC. X. XXXX PRICE MULTI-SECTOR ACCOUNT PORTFOLIOS, INC. X. Xxxx Price Emerging Markets Corporate Multi-Sector Account Portfolio X. Xxxx Price Emerging Markets Local Multi-Sector Account Portfolio X. Xxxx Price Floating Rate Multi-Sector Account Portfolio X. Xxxx Price High Yield Multi-Sector Account Portfolio X. Xxxx Price Investment-Grade Corporate Multi-Sector Account Portfolio X. Xxxx Price Mortgage-Backed Securities Multi-Sector Account Portfolio X. XXXX PRICE NEW AMERICA GROWTH FUND X. XXXX PRICE NEW ERA FUND, INC. X. XXXX PRICE NEW HORIZONS FUND, INC. CHEWY NHF, LLC Encapsys NHF, LLC WF NHF I, LLC X. XXXX PRICE NEW INCOME FUND, INC. X. XXXX PRICE PERSONAL STRATEGY FUNDS, INC. X. Xxxx Price Personal Strategy Balanced Fund X. Xxxx Price Personal Strategy Growth Fund X. Xxxx Price Personal Strategy Income Fund X. XXXX PRICE PRIME RESERVE FUND, INC. X. XXXX PRICE REAL ASSETS FUND, INC. X. XXXX PRICE REAL ESTATE FUND, INC. X. XXXX PRICE RESERVE INVESTMENT FUNDS, INC. X. Xxxx Price Government Reserve Investment Fund X. Xxxx Price Reserve Investment Fund X. Xxxx Price Short-Term Government Reserve Fund X. Xxxx Price Short-Term Reserve Fund X. XXXX PRICE RETIREMENT FUNDS, INC. X. Xxxx Price Retirement 2005 Fund X. Xxxx Price Retirement 2010 Fund X. Xxxx Price Retirement 2015 Fund X. Xxxx Price Retirement 2020 Fund X. Xxxx Price Retirement 2025 Fund X. Xxxx Price Retirement 2030 Fund X. Xxxx Price Retirement 2035 Fund X. Xxxx Price Retirement 2040 Fund X. Xxxx Price Retirement 2045 Fund X. Xxxx Price Retirement 2050 Fund X. Xxxx Price Retirement 2055 Fund X. Xxxx Price Retirement 2060 Fund X. Xxxx Price Retirement Balanced Fund X. Xxxx Price Target 2005 Fund X. Xxxx Price Target 2010 Fund X. Xxxx Price Target 2015 Fund X. Xxxx Price Target 2020 Fund X. Xxxx Price Target 2025 Fund X. Xxxx Price Target 2030 Fund X. Xxxx Price Target 2035 Fund X. Xxxx Price Target 2040 Fund X. Xxxx Price Target 2045 Fund X. Xxxx Price Target 2050 Fund X. Xxxx Price Target 2055 Fund X. Xxxx Price Target 2060 Fund X. XXXX PRICE SCIENCE & TECHNOLOGY FUND, INC. X. XXXX PRICE SHORT-TERM BOND FUND, INC. X. Xxxx Price Ultra Short-Term Bond Fund X. XXXX PRICE SMALL-CAP STOCK FUND, INC. X. XXXX PRICE SMALL-CAP VALUE FUND, INC. CHEWY SCVF, LLC

  • Joint Development Committee (a) The Parties shall establish a Joint Development Committee (the “Joint Development Committee” or “JDC”), comprised of [**] representatives of Ikaria and [**] representatives of BioLineRx, to oversee the Development of Products. Each Party shall make its initial designation of its representatives not later than [**] days after the Effective Date. Each Party may change any one or more of its representatives to the Joint Development Committee at any time upon notice to the other Party. (b) The JDC shall meet at least [**] during the Development Term or more or less frequently as the JDC may agree. The JDC may meet in person or by means of a telephone or video conference call. One meeting of the JDC per year shall be held in person at Ikaria’s headquarters in Clinton, NJ and one meeting of the JDC per year shall be held in person at BioLineRx’s headquarters in Israel, provided, that the Parties’ representatives may participate in person, via telephone, or video conference in their discretion. Each Party shall use reasonable efforts to cause its representatives to attend the meetings of the JDC. If a representative of a Party is unable to attend a meeting, such Party may designate an alternate to attend such meeting in place of the absent representative. Each Party shall bear its own costs with respect to its participation on the JDC. Prior to every meeting of the JDC, Ikaria will provide to the JDC detailed reports describing Ikaria’s current clinical and development activities and plans. (c) The JDC shall be the vehicle by which BioLineRx may offer insight and guidance to Ikaria with respect to (i) establishing the Development Plan setting forth the Development Program’s objectives and the activities to be conducted, (ii) reviewing and updating the Development Plan from time to time, (iii) monitoring the progress and results of the Development Program, (iv) determining future Development Program activities, including Development activities relating to Manufacturing, to be conducted during the Development Term, and (v) establishing success criteria for the clinical trials (other than those for which success criteria are set forth in this Agreement), and determining whether the results of such clinical trials have achieved the applicable success criteria. (d) The JDC shall only act unanimously, with each Party given one (1) vote regardless of the number of representatives. If, however, the JDC is unable to reach agreement with respect to any matter within [**] days, the matter shall be referred to the Parties’ respective Executive Officers for resolution. If the Executive Officers are not able to resolve any such matter by consensus within [**] days following referral, Ikaria’s Executive Officer shall have the right to decide the matter taking into account Ikaria’s obligation to use Commercially Reasonable Efforts under Section 3.8. Notwithstanding anything in this Section 3.2, neither Party shall have a unilateral right to resolve any dispute involving the breach or alleged breach of this Agreement, to amend or modify this Agreement or the Parties’ respective rights and obligations hereunder or, except as expressly provided in this Section 3.2, any Development Plan or the Parties’ respective rights and obligations thereunder.

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!